Bio Essence (BIOE) FCF Margin (2020 - 2026)
Bio Essence (BIOE) recorded quarterly FCF Margin of 82.31% in Q1 2026, down 198.12% quarter-over-quarter from 83.89% in Q4 2025, and up 3518.0% on a YoY basis from 2.27% in Q1 2025.
Bio Essence (BIOE) FCF Margin (2020 - 2026) Analysis & Trends
Bio Essence's FCF Margin history runs 7 years deep, the most recent figure standing at 82.31% for Q1 2026.
- In Q1 2026, FCF Margin rose 3518.0% year-over-year to 82.31%; the TTM figure through Mar 2026 stood at 49.83% (down 17707.0% YoY), while the FY2025 annual figure was 82.72%, down 11479.0% from the prior year.
- FCF Margin was 82.31% for Q1 2026 at Bio Essence, down from 83.89% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 297.53% in Q4 2024 to a low of 447.57% in Q3 2023.
- Historically, FCF Margin has averaged 1.09% across 5 years, with a median of 36.63% in 2024.
- The sharpest annual moves came in 2023 and 2024: FCF Margin tumbled 35263 bps in 2023, then soared 71273 bps in 2024.
- A 5-year view of FCF Margin shows it stood at 48.14% in 2022, then jumped by 62 bps to 77.96% in 2023, then jumped by 282 bps to 297.53% in 2024, then slumped by 72 bps to 83.89% in 2025, then sank by 198 bps to 82.31% in 2026.
- The last three FCF Margin figures came in at 82.31% (Q1 2026), 83.89% (Q4 2025), and 136.68% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Bio Essence | - | - | 319,353.00 | -82.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.31% |
| Dec 31, 2025 | 83.89% |
| Sep 30, 2025 | 136.68% |
| Jun 30, 2025 | 64.76% |
| Mar 31, 2025 | -117.49% |
| Dec 31, 2024 | 297.53% |
| Sep 30, 2024 | 265.16% |
| Jun 30, 2024 | 36.63% |
| Mar 31, 2024 | -111.53% |
| Dec 31, 2023 | 77.96% |
| Sep 30, 2023 | -447.57% |
| Jun 30, 2023 | 41.22% |
| Mar 31, 2023 | -67.89% |
| Dec 31, 2022 | 48.14% |
| Sep 30, 2022 | -94.94% |
| Jun 30, 2022 | -65.67% |
| Mar 31, 2022 | -83.05% |
| Dec 31, 2021 | -109.09% |
| Sep 30, 2021 | -80.24% |
| Jun 30, 2021 | -352.18% |